Published in J Immunol on October 01, 2005
Mast cells and mastocytosis. Blood (2008) 2.32
Development, migration, and survival of mast cells. Immunol Res (2006) 1.78
A beneficial role for immunoglobulin E in host defense against honeybee venom. Immunity (2013) 1.71
Our perception of the mast cell from Paul Ehrlich to now. Eur J Immunol (2009) 1.39
Antibodies specific for a segment of human membrane IgE deplete IgE-producing B cells in humanized mice. J Clin Invest (2010) 1.36
Beyond immediate hypersensitivity: evolving roles for IgE antibodies in immune homeostasis and allergic diseases. Immunol Rev (2011) 1.28
TLR signaling in mast cells: common and unique features. Front Immunol (2012) 1.12
New concepts in chronic urticaria. Curr Opin Immunol (2008) 1.08
Impaired degranulation but enhanced cytokine production after Fc epsilonRI stimulation of diacylglycerol kinase zeta-deficient mast cells. J Exp Med (2006) 1.02
IgE influences the number and function of mature mast cells, but not progenitor recruitment in allergic pulmonary inflammation. J Immunol (2009) 1.01
Immunoglobulin E signal inhibition during allergen ingestion leads to reversal of established food allergy and induction of regulatory T cells. Immunity (2014) 0.97
IgE alone promotes human lung mast cell survival through the autocrine production of IL-6. BMC Immunol (2008) 0.94
Most Highly Cytokinergic IgEs Have Polyreactivity to Autoantigens. Allergy Asthma Immunol Res (2012) 0.93
Polyclonal IgE induces mast cell survival and cytokine production. Allergol Int (2009) 0.92
Proinflammatory and Th2 cytokines regulate the high affinity IgE receptor (FcepsilonRI) and IgE-dependant activation of human airway smooth muscle cells. PLoS One (2009) 0.91
Mast cell biology: introduction and overview. Adv Exp Med Biol (2011) 0.89
Cytokinergic IgE Action in Mast Cell Activation. Front Immunol (2012) 0.88
The Mast Cell-IgE Paradox: From Homeostasis to Anaphylaxis. Am J Pathol (2016) 0.88
Fluorogen-activating proteins provide tunable labeling densities for tracking FcεRI independent of IgE. ACS Chem Biol (2014) 0.87
IgE induces proliferation in human airway smooth muscle cells: role of MAPK and STAT3 pathways. Allergy Asthma Clin Immunol (2013) 0.84
Pivotal advance: IgE accelerates in vitro development of mast cells and modifies their phenotype. J Leukoc Biol (2008) 0.83
Characterization of leukocyte mono-immunoglobulin-like receptor 7 (LMIR7)/CLM-3 as an activating receptor: its similarities to and differences from LMIR4/CLM-5. J Biol Chem (2010) 0.83
Fifty years later: Emerging functions of IgE antibodies in host defense, immune regulation, and allergic diseases. J Allergy Clin Immunol (2016) 0.82
LAT and NTAL mediate immunoglobulin E-induced sustained extracellular signal-regulated kinase activation critical for mast cell survival. Mol Cell Biol (2007) 0.81
IgE-FcepsilonRI interactions determine HIV coreceptor usage and susceptibility to infection during ontogeny of mast cells. J Immunol (2009) 0.80
Blunted IgE-mediated activation of mast cells in mice lacking the serum- and glucocorticoid-inducible kinase SGK3. Am J Physiol Cell Physiol (2010) 0.79
Serum- and glucocorticoid-inducible kinase 1 in the regulation of renal and extrarenal potassium transport. Clin Exp Nephrol (2011) 0.79
Helicobacter pylori infection in patients with selective immunoglobulin E deficiency. World J Gastroenterol (2015) 0.78
Selective IgE deficiency and cardiovascular diseases. Allergy Asthma Proc (2015) 0.78
Mechanism of the antigen-independent cytokinergic SPE-7 IgE activation of human mast cells in vitro. Sci Rep (2015) 0.77
Possible therapeutic role of IgE blockade in irritable bowel syndrome. World J Gastroenterol (2016) 0.75
Allergen-independent immunomodulatory activities of immunoglobulin E. Clin Exp Allergy (2009) 0.75
Fcepsilon- and Fcgamma-receptor signaling in diseases. Springer Semin Immunopathol (2006) 0.75
Evidence that integrin alpha IIb beta 3-dependent interaction of mast cells with fibrinogen exacerbates chronic inflammation. J Biol Chem (2009) 0.75
From IgE to Omalizumab. J Immunol (2016) 0.75
Mast Cells and IgE can Enhance Survival During Innate and Acquired Host Responses to Venoms. Trans Am Clin Climatol Assoc (2017) 0.75
IgE Trimers Drive SPE-7 Cytokinergic Activity. Sci Rep (2017) 0.75
FceRI density and spontaneous secretion from human basophils. PLoS One (2017) 0.75
Signal transduction by receptors with tyrosine kinase activity. Cell (1990) 22.72
Monoclonal dinitrophenyl-specific murine IgE antibody: preparation, isolation, and characterization. J Immunol (1980) 6.69
Dimerization of cell surface receptors in signal transduction. Cell (1995) 6.58
Inflammatory mast cells up-regulate angiogenesis during squamous epithelial carcinogenesis. Genes Dev (1999) 6.10
Mast cells: a cellular link between autoantibodies and inflammatory arthritis. Science (2002) 5.82
Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNF-alpha. Nature (1996) 5.48
Antibody multispecificity mediated by conformational diversity. Science (2003) 5.21
Mast cell lines produce lymphokines in response to cross-linkage of Fc epsilon RI or to calcium ionophores. Nature (1989) 5.10
Mast cells in the development of adaptive immune responses. Nat Immunol (2005) 4.96
Critical protective role of mast cells in a model of acute septic peritonitis. Nature (1996) 4.71
The high-affinity IgE receptor (Fc epsilon RI): from physiology to pathology. Annu Rev Immunol (1999) 4.62
Fyn kinase initiates complementary signals required for IgE-dependent mast cell degranulation. Nat Immunol (2002) 3.60
Regulation of mast-cell and basophil function and survival by IgE. Nat Rev Immunol (2002) 2.96
Compartmentalized activation of the high affinity immunoglobulin E receptor within membrane domains. J Biol Chem (1997) 2.83
Role for interleukin-3 in mast-cell and basophil development and in immunity to parasites. Nature (1998) 2.82
The biology of IGE and the basis of allergic disease. Annu Rev Immunol (2001) 2.80
Development of atopic dermatitis-like skin lesion with IgE hyperproduction in NC/Nga mice. Int Immunol (1997) 2.79
Mast cells are essential for early onset and severe disease in a murine model of multiple sclerosis. J Exp Med (2000) 2.54
Signalling through the high-affinity IgE receptor Fc epsilonRI. Nature (1999) 2.54
IgE enhances mouse mast cell Fc(epsilon)RI expression in vitro and in vivo: evidence for a novel amplification mechanism in IgE-dependent reactions. J Exp Med (1997) 2.48
Transactivation of sphingosine-1-phosphate receptors by FcepsilonRI triggering is required for normal mast cell degranulation and chemotaxis. J Exp Med (2004) 2.44
Leukotriene B4 receptor BLT1 mediates early effector T cell recruitment. Nat Immunol (2003) 2.39
Active anaphylaxis in IgE-deficient mice. Nature (1994) 2.32
Fc epsilon RI-mediated recruitment of p53/56lyn to detergent-resistant membrane domains accompanies cellular signaling. Proc Natl Acad Sci U S A (1995) 2.30
Phosphoinositide 3-kinase gamma is an essential amplifier of mast cell function. Immunity (2002) 2.25
Signaling life and death in the thymus: timing is everything. Science (2003) 2.20
Recruitment of neutrophils during IgE-dependent cutaneous late phase reactions in the mouse is mast cell-dependent. Partial inhibition of the reaction with antiserum against tumor necrosis factor-alpha. J Clin Invest (1991) 2.14
Generation of hybridomas secreting murine reaginic antibodies of anti-DNP specificity. J Immunol (1980) 2.14
Regulation of mast cell survival by IgE. Immunity (2001) 2.11
Monomeric IgE stimulates signaling pathways in mast cells that lead to cytokine production and cell survival. Immunity (2001) 2.11
Signal transduction by Fc receptors: the Fc epsilon RI case. Immunol Today (1993) 2.04
Roles of mast cells and basophils in innate and acquired immunity. Curr Opin Immunol (2000) 2.02
Mast cells control neutrophil recruitment during T cell-mediated delayed-type hypersensitivity reactions through tumor necrosis factor and macrophage inflammatory protein 2. J Exp Med (2000) 2.00
Evidence that IgE molecules mediate a spectrum of effects on mast cell survival and activation via aggregation of the FcepsilonRI. Proc Natl Acad Sci U S A (2003) 1.94
Leukotriene B4 and BLT1 control cytotoxic effector T cell recruitment to inflamed tissues. Nat Immunol (2003) 1.86
Mast cells as sentinels of innate immunity. Curr Opin Immunol (1999) 1.85
The nonimmunoglobulin portion of lambda5 mediates cell-autonomous pre-B cell receptor signaling. Nat Immunol (2003) 1.75
Mast cell-dependent migration of effector CD8+ T cells through production of leukotriene B4. Nat Immunol (2003) 1.69
The diverse roles of mast cells. J Exp Med (2001) 1.61
The c-kit ligand, stem cell factor, promotes mast cell survival by suppressing apoptosis. Am J Pathol (1994) 1.53
Immune sensitization in the skin is enhanced by antigen-independent effects of IgE. Immunity (2004) 1.53
Evidence for a role of mast cells in the evolution to congestive heart failure. J Exp Med (2002) 1.52
Mast cell signal transduction from the high-affinity IgE receptor. Curr Opin Immunol (2003) 1.49
Stat5 expression is critical for mast cell development and survival. Blood (2003) 1.48
Studies of IgE-dependent histamine releasing factors: heterogeneity of IgE. J Immunol (1987) 1.32
Necessity of IgE antibodies and mast cells for manifestation of resistance against larval Haemaphysalis longicornis ticks in mice. J Immunol (1990) 1.32
The receptor for immunoglobulin E on rat basophilic leukemia cells: effect of ligand binding on receptor expression. Proc Natl Acad Sci U S A (1985) 1.21
Essential role of the prosurvival bcl-2 homologue A1 in mast cell survival after allergic activation. J Exp Med (2001) 1.20
IgE antibody up-regulates high affinity IgE binding on murine bone marrow-derived mast cells. Immunol Lett (1996) 1.20
IgE enhances parasite clearance and regulates mast cell responses in mice infected with Trichinella spiralis. J Immunol (2004) 1.18
Early divergence of Fc epsilon receptor I signals for receptor up-regulation and internalization from degranulation, cytokine production, and survival. J Immunol (2004) 1.16
Rapid and large amount of autocrine IL-3 production is responsible for mast cell survival by IgE in the absence of antigen. Blood (2004) 1.15
Proapoptotic Bcl-2 family member Bim is involved in the control of mast cell survival and is induced together with Bcl-XL upon IgE-receptor activation. Cell Death Differ (2005) 1.15
Minimal requirements for IgE-mediated regulation of surface Fc epsilon RI. J Immunol (2001) 1.14
Effects of histamine on Th1/Th2 cytokine balance. Int Immunopharmacol (2003) 1.11
Monomeric IgE stimulates NFAT translocation into the nucleus, a rise in cytosol Ca2+, degranulation, and membrane ruffling in the cultured rat basophilic leukemia-2H3 mast cell line. J Immunol (2004) 1.10
Analysis of immunoglobulin E VH transcripts in a bronchial biopsy of an asthmatic patient confirms bias towards VH5, and indicates local clonal expansion, somatic mutation and isotype switch events. Immunology (1999) 1.06
IgE- and IgE+Ag-mediated mast cell migration in an autocrine/paracrine fashion. Blood (2005) 1.06
Expression of epsilon germ-line gene transcripts and mRNA for the epsilon heavy chain of IgE in nasal B cells and the effects of topical corticosteroid. Eur J Immunol (1997) 1.06
Local expression of epsilon germline gene transcripts and RNA for the epsilon heavy chain of IgE in the bronchial mucosa in atopic and nonatopic asthma. J Allergy Clin Immunol (2001) 1.05
Drastic up-regulation of Fcepsilonri on mast cells is induced by IgE binding through stabilization and accumulation of Fcepsilonri on the cell surface. J Immunol (2001) 1.05
IgE alone stimulates mast cell adhesion to fibronectin via pathways similar to those used by IgE + antigen but distinct from those used by Steel factor. Blood (2003) 1.03
Death of a dogma or enforcing the artificial: monomeric IgE binding may initiate mast cell response by inducing its receptor aggregation. J Immunol (2005) 1.03
IgE alone-induced actin assembly modifies calcium signaling and degranulation in RBL-2H3 mast cells. Am J Physiol Cell Physiol (2003) 1.02
Local somatic hypermutation and class switch recombination in the nasal mucosa of allergic rhinitis patients. J Immunol (2003) 1.02
Mast-cell-leukocyte cytokine cascades in allergic inflammation. Allergy (1995) 1.01
Generation of a large number of connective tissue type mast cells by culture of murine fetal skin cells. J Invest Dermatol (2003) 1.00
Regulation of highly cytokinergic IgE-induced mast cell adhesion by Src, Syk, Tec, and protein kinase C family kinases. J Immunol (2005) 0.99
The quantity and duration of FcRgamma signals determine mast cell degranulation and survival. Blood (2003) 0.98
Fc epsilon RI gamma-ITAM is differentially required for mast cell function in vivo. J Immunol (2004) 0.98
Production of macrophage inflammatory protein-1alpha by human mast cells: increased anti-IgE-dependent secretion after IgE-dependent enhancement of mast cell IgE-binding ability. Lab Invest (1997) 0.97
Human cord blood-derived mast cells synthesize and release I-309 in response to IgE. Life Sci (2003) 0.93
An immunoglobulin E-dependent recombinant histamine-releasing factor induces interleukin-4 secretion from human basophils. J Exp Med (1996) 0.91
Glucocorticoid suppresses autocrine survival of mast cells by inhibiting IL-4 production and ICAM-1 expression. J Immunol (1999) 0.89
Persistent IgE synthesis in the nasal mucosa of hay fever patients. Eur J Immunol (2001) 0.89
Stimulation of connective tissue-type mast cell proliferation by crosslinking of cell-bound IgE. J Exp Med (1989) 0.87
Ca2+ influx-mediated histamine synthesis and IL-6 release in mast cells activated by monomeric IgE. Eur J Immunol (2005) 0.86
Antigen-independent induction of histamine synthesis by immunoglobulin E in mouse bone marrow-derived mast cells. J Exp Med (2002) 0.85
Enhanced expression of Fas-associated death domain-like IL-1-converting enzyme (FLICE)-inhibitory protein induces resistance to Fas-mediated apoptosis in activated mast cells. J Immunol (2000) 0.85
The relationship between immunological responsiveness controlled by T-helper 2 lymphocytes and infections with parasitic helminths. Parasitology (1997) 0.81
Expression of IL-4, Cepsilon RNA, and Iepsilon RNA in the nasal mucosa of patients with seasonal rhinitis: effect of topical corticosteroids. J Allergy Clin Immunol (1998) 0.80
Establishment of antigen-specific IgE transgenic mice to study pathological and immunobiological roles of IgE in vivo. Int Immunol (1999) 0.79
p28, a novel IgE receptor-associated protein, is a sensor of receptor occupation by its ligand in mast cells. J Biol Chem (2004) 0.79
Role of IgE as a mast cell development co-factor in the differentiation of murine gut-associated mast cells in vitro. Eur J Immunol (1986) 0.76
AML1 mutations induced MDS and MDS/AML in a mouse BMT model. Blood (2008) 2.03
Hes1 immortalizes committed progenitors and plays a role in blast crisis transition in chronic myelogenous leukemia. Blood (2009) 1.78
Protein kinase C betaII regulates Akt phosphorylation on Ser-473 in a cell type- and stimulus-specific fashion. J Biol Chem (2004) 1.49
G-protein-coupled receptor signaling in Syk-deficient neutrophils and mast cells. Blood (2003) 1.30
TIM1 is an endogenous ligand for LMIR5/CD300b: LMIR5 deficiency ameliorates mouse kidney ischemia/reperfusion injury. J Exp Med (2010) 1.29
Regulation of dendritic cell maturation and function by Bruton's tyrosine kinase via IL-10 and Stat3. Proc Natl Acad Sci U S A (2005) 1.28
Positive and negative regulation of mast cell activation by Lyn via the FcepsilonRI. J Immunol (2005) 1.25
The Src family kinase Hck regulates mast cell activation by suppressing an inhibitory Src family kinase Lyn. Blood (2007) 1.24
The receptor LMIR3 negatively regulates mast cell activation and allergic responses by binding to extracellular ceramide. Immunity (2012) 1.15
An activating and inhibitory signal from an inhibitory receptor LMIR3/CLM-1: LMIR3 augments lipopolysaccharide response through association with FcRgamma in mast cells. J Immunol (2009) 1.13
Myelodysplastic syndromes are induced by histone methylation–altering ASXL1 mutations. J Clin Invest (2013) 1.12
Functional analysis of activating receptor LMIR4 as a counterpart of inhibitory receptor LMIR3. J Biol Chem (2007) 1.12
Analysis of mouse LMIR5/CLM-7 as an activating receptor: differential regulation of LMIR5/CLM-7 in mouse versus human cells. Blood (2007) 1.04
A Ras activation pathway dependent on Syk phosphorylation of protein kinase C. Proc Natl Acad Sci U S A (2003) 1.01
Protein kinase C beta (PKC beta): normal functions and diseases. J Biochem (2002) 1.00
O-methylated catechins from tea leaves inhibit multiple protein kinases in mast cells. J Immunol (2004) 0.98
Enhanced expression of p210BCR/ABL and aberrant expression of Zfp423/ZNF423 induce blast crisis of chronic myelogenous leukemia. Blood (2009) 0.94
Histamine-releasing factor has a proinflammatory role in mouse models of asthma and allergy. J Clin Invest (2011) 0.93
Two types of C/EBPα mutations play distinct but collaborative roles in leukemogenesis: lessons from clinical data and BMT models. Blood (2010) 0.92
Transforming growth factor-β-stimulated clone-22 is a negative-feedback regulator of Ras / Raf signaling: Implications for tumorigenesis. Cancer Sci (2011) 0.92
A soluble form of LMIR5/CD300b amplifies lipopolysaccharide-induced lethal inflammation in sepsis. J Immunol (2012) 0.88
Molecular bases of myelodysplastic syndromes: lessons from animal models. J Cell Physiol (2009) 0.85
Pivotal advance: IgE accelerates in vitro development of mast cells and modifies their phenotype. J Leukoc Biol (2008) 0.83
PRAT4A-dependent expression of cell surface TLR5 on neutrophils, classical monocytes and dendritic cells. Int Immunol (2012) 0.83
Identification of RHOXF2 (PEPP2) as a cancer-promoting gene by expression cloning. Int J Oncol (2011) 0.83
Characterization of leukocyte mono-immunoglobulin-like receptor 7 (LMIR7)/CLM-3 as an activating receptor: its similarities to and differences from LMIR4/CLM-5. J Biol Chem (2010) 0.83
The shortest isoform of C/EBPβ, liver inhibitory protein (LIP), collaborates with Evi1 to induce AML in a mouse BMT model. Blood (2013) 0.81
IgE regulation of mast cell survival and function. Novartis Found Symp (2005) 0.81
Possible involvement of RasGRP4 in leukemogenesis. Int J Hematol (2009) 0.81
APC(CDH1) targets MgcRacGAP for destruction in the late M phase. PLoS One (2013) 0.80
Human CD300C delivers an Fc receptor-γ-dependent activating signal in mast cells and monocytes and differs from CD300A in ligand recognition. J Biol Chem (2013) 0.79
The molecular basis of myeloid malignancies. Proc Jpn Acad Ser B Phys Biol Sci (2014) 0.78
Integrin alphaIIbbeta3 induces the adhesion and activation of mast cells through interaction with fibrinogen. J Immunol (2006) 0.78
Techniques to study Fc epsilonRI signaling. Methods Mol Biol (2006) 0.78
[Regulation of mast cell survival and activation by monomeric IgE]. Arerugi (2004) 0.77
MicroRNA-125b-1 accelerates a C-terminal mutant of C/EBPα (C/EBPα-C(m))-induced myeloid leukemia. Int J Hematol (2012) 0.77
[Molecular mechanisms underlying leukemic transformation of myelodysplastic syndromes (MDS) and chronic myelogenous leukemia (CML)]. Rinsho Ketsueki (2012) 0.77
Upregulation of CD200R1 in lineage-negative leukemic cells is characteristic of AML1-ETO-positive leukemia in mice. Int J Hematol (2012) 0.77
Fyn is not essential for Bcr-Abl-induced leukemogenesis in mouse bone marrow transplantation models. Int J Hematol (2011) 0.76
Evidence that integrin alpha IIb beta 3-dependent interaction of mast cells with fibrinogen exacerbates chronic inflammation. J Biol Chem (2009) 0.75
[The shortest isoform of C/EBPβ, Liver inhibitory protein (LIP), collaborates with Evi1 to induce AML in a mouse BMT model]. Rinsho Ketsueki (2013) 0.75
[Molecular basis of hematological malignancies]. Rinsho Ketsueki (2014) 0.75